Sterile inflammation as a factor in human male infertility ...
Mr Ted McDermott, Consultant Urologist...Incidence 15% of couples 30% male factor only 20% male &...
Transcript of Mr Ted McDermott, Consultant Urologist...Incidence 15% of couples 30% male factor only 20% male &...
Male Factor InfertilityMr Ted McDermott, Consultant Urologist
Male Factor Infertility
Definiton: Inability to achieve pregnancy after one year
of unprotected intercourse
Mr Ted McDermott, Consultant Urologist
Incidence
15% of couples
30% male factor only
20% male & female factor
Male factors: 70% diagnosed by non-invasive cost
efficient investigations
Mr Ted McDermott, Consultant Urologist
Treatment
Depends on underlying aetiology
Optimizing sperm production
Surgery may be individually optimized
More complex problems may need IVF/ICSI
Mr Ted McDermott, Consultant Urologist
Pathophysiology
Hypothalamus GnRH
GnRH Pituitary
Pituitary FSH + LH
FSH Sertoli cells for
sperm
LH Leydig cells for
testosterone + inhibin
Mr Ted McDermott, Consultant Urologist
Incidence
15% of couples BUT
23% conceive within 2 years
10% more conceive within 4 ½ years
7.6% conceive with counts <2million
Mr Ted McDermott, Consultant Urologist
Global sperm count trend
113 million/cc in 1940
66 million/cc in 1990
? Patients presenting
Counting techniques
Toxins in environment
Geographic presentation
Mr Ted McDermott, Consultant Urologist
Morbidity and Mortality
Associated with;
Pituitary Adenoma
Testicular Cancer
Liver Failure
Renal Failure
Increased overall lifetime risk of cancer of 2.2% vs 1.1%
Mr Ted McDermott, Consultant Urologist
Age
Reduced fertility with age
50% of sperm lost by 50 years
Mr Ted McDermott, Consultant Urologist
Patient Evaluation
History:
Duration of infertility
Previous Fertility
Sexual History
Childhood Urological Procedures
PMHx:
Testis Cancer
Diabetes
Other Cancer
Obesity
Respiratory Diseases STD
Medication: Testosterone
Social History:
Excessive sporting activity, Hash,
Alcohol, Emotional Stressors,
Environmental exposures
Drugs:
Chemotherapy, Tetracycline,
Nitrofurantoin
Mr Ted McDermott, Consultant Urologist
Physical Examination
Body Habitus
Secondary sexual characteristics
Penis Abnormalities
Testes for position
Size: 3-4cm
Vas
Varicocele
Mr Ted McDermott, Consultant Urologist
Diagnosis
Semen analysis
pH 7.05 – 7.8
Density 15 million/cc
Motility – 40% normal movement
Morphology – 4% upwards
Infection – round or white cell elevation
Antisperm antibody
Blood
Hormone and genetic typing
FSH, LH, Prolactin, Testosterone
Mr Ted McDermott, Consultant Urologist
Testosterone
Diurnal pattern
Higher in the morning
Excessive levels inhibit GnRH
Intratesticular is a separate issue
Mr Ted McDermott, Consultant Urologist
Sperm Production
74 days
16 steps
Spermatids (Stage 6 used for ICSI)
Epididymis (Sperm maturation to
allow egg penetration)
Ejaculatory Content – Seminal
vesicles 40-80% including fructose
Prostate Gland 10 – 30%
Sperm 5%
Cowper Glands 2-5%
Mr Ted McDermott, Consultant Urologist
Correctable Causes
Varicocele
15% males, left side, right side suggests secondary pathology
Repair results in 40-70% improved semen parameters
Surgery versus Embolization in Radiology
Low Testosterone
Treat with Clomid
Stimulates GnRH release
Vasectomy
60-70% success at 5 years
Anejaculation
Vibrator
Electroejaculation
ICSI
Retrograde Ejaculation
Sudafed
Collection of retrograde sample
IVF and ICSI have covered the gaps in our treatment options
Mr Ted McDermott, Consultant Urologist
Mr Ted McDermott, Consultant Urologist
Mr Ted McDermott, Consultant Urologist
Mr Ted McDermott, Consultant Urologist
Mr Ted McDermott, Consultant Urologist
Introducing the UroLift® System
20
The Prostatic Urethral Lift
Compress encroaching lateral lobe
Deliver UroLift® implant to hold in place
Typically ~4 implants deliveredMr Ted McDermott, Consultant Urologist
Immediate UroLift® Effect
Mechanically opens prostatic urethra
Result is visible under cystoscopy
Implants are anterolateral, away from NV bundles or dorsal venous complex
PRE POST
Mr Ted McDermott, Consultant Urologist
Where Does UroLift® Fit?
Mr Ted McDermott, Consultant Urologist
All BPH/LUTS Patients Should be Considered!
Men Who:
Are frustrated by side-effects or daily hassle of
medication
Have modest symptomatic relief from medications
Previously declined surgery
Want to preserve their sexual function Mr Ted McDermott, Consultant Urologist
Urolift Summary
Rapid relief
IPSS reduced 10-12 points, Qmax increased 4 mLs
Significant improvement by 2 weeks
Adverse effects mild/moderate resolve by 2-4 weeks
Preserves ejaculatory and erectile function
Well tolerated under local anesthesia
Durability to 5 years established
Consistent performance across global studies
Mr Ted McDermott, Consultant Urologist
Mr Ted McDermott, Consultant Urologist